6505NCM195828: TECOVIRIMAT MONOHYDRATE,CAPSULE.
TECOVIRIMAT MONOHYDRATE,CAPSULE. Key specifications include part_name_assigned_by_controlling_agency: SMALLPOX TREATMENT, TECOVIRIMAT(TPOXX), 42 CAPSULES, 200MG. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-684-9538, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | SMALLPOX TREATMENT, TECOVIRIMAT(TPOXX), 42 CAPSULES, 200MG |
| NSN | 6505-01-684-9538 |
| SPECIAL FEATURES | TPOXX IS INDICATED FOR THE TREATMENT OF HUMAN SMALLPOX DISEASE CAUSED BY VARIOLA VIRUS IN ADULTS AND PEDIATRIC PATIENS WEGHING AT LEAST 13 KG(28.66LBS); TPOXX(TECOVIRIMAT) IS AN INHIBITOR OF THE ORTHOPOX VIRUS VP37 ENVELOPE WRAPPING PROTEIN; EACH CAPSULE CONTAINS 200 MG OF TECOVIRIMAT; EACH BOTTLE CONTAINS 42 CAPSULES WITH AN INDUCTION SEAL AND CHILD-RESISTANT CAP; STORE CAPSULES IN THE ORIGINAL BOTTLE AT 20C TO 25C (68F TO 77F); EXCURSIONS PERMITTED 15C TO 30C (59F TO 86F) SEE USP CONTROLLED ROOM TEMPERATURE. LBS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | SMALLPOX TREATMENT, TECOVIRIMAT(TPOXX), 42 CAPSULES, 200MG |